Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Farmers Insurance
Cipla
McKesson
Julphar
QuintilesIMS
Chubb
Cantor Fitzgerald
Harvard Business School

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084697

« Back to Dashboard

NDA 084697 describes ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN, which is a drug marketed by Septodont Inc and is included in one NDA. Additional details are available on the ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN profile page.

The generic ingredient in ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 084697
Tradename:ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN
Applicant:Septodont Inc
Ingredient:levonordefrin; mepivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.05MG/ML;2%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Teva
Cantor Fitzgerald
Argus Health
Healthtrust
Federal Trade Commission
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot